Correction: Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
(Source: Radiation Oncology)
Source: Radiation Oncology - March 3, 2023 Category: Cancer & Oncology Authors: Masanori Hirata, Kazuaki Yasui, Naofumi Oota, Hirofumi Ogawa, Tsuyoshi Onoe, Sayo Maki, Yusuke Ito, Kenji Hayashi, Hirofumi Asakura, Shigeyuki Murayama, Koichi Mitsuya, Shoichi Deguchi, Katsumasa Nakamura, Nakamasa Hayashi, Tetsuo Nishimura and Hideyuki H Tags: Correction Source Type: research
Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
Conventional treatment of pulmonary metastatic sarcoma primarily involves surgery, with systemic therapy added in select patients. However, broader applications of radiation therapy techniques have prompted in... (Source: Radiation Oncology)
Source: Radiation Oncology - March 1, 2023 Category: Cancer & Oncology Authors: Paulina M. Gutkin, Elizabeth Gore, John Charlson, John C. Neilson, Candice Johnstone, David M. King, Donald A. Hackbarth, Adam Wooldridge, Rajeev Mannem and Meena Bedi Tags: Research Source Type: research
A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma
Methylprednisolone is recommended as the front-line therapy for radiation-induced brain necrosis (RN) after radiotherapy for nasopharyngeal carcinoma. However, some patients fail to benefit from methylpredniso... (Source: Radiation Oncology)
Source: Radiation Oncology - March 1, 2023 Category: Cancer & Oncology Authors: Xiaohuang Zhuo, Huiying Zhao, Meiwei Chen, Youqing Mu, Yi Li, Jinhua Cai, Honghong Li, Yongteng Xu and Yamei Tang Tags: Research Source Type: research
Prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma treated with definitive (chemo)radiotherapy
To investigate the prognostic value of baseline 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma (ESCC) treated with definitive (chemo)radiotherapy. (Source: Radiation Oncology)
Source: Radiation Oncology - February 24, 2023 Category: Cancer & Oncology Authors: Lianshuang Xia, Xiaoxu Li, Jie Zhu, Zhaisong Gao, Ju Zhang, Guangjie Yang and Zhenguang Wang Tags: Research Source Type: research
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis
High-dose proton beam therapy (PBT) uses excellent dose concentricity based on the unique characteristic termed the Bragg peak. PBT is a highly feasible treatment option that improves survival in select patien... (Source: Radiation Oncology)
Source: Radiation Oncology - February 23, 2023 Category: Cancer & Oncology Authors: Masahide Matsuda, Masashi Mizumoto, Hidehiro Kohzuki, Narushi Sugii, Hideyuki Sakurai and Eiichi Ishikawa Tags: Research Source Type: research
Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis
To investigate whether the rate of stereotactic body radiation therapy-related (SBRT-related) genitourinary (GU) toxicity is lower in patients with prostate cancer treated with CyberKnife. (Source: Radiation Oncology)
Source: Radiation Oncology - February 23, 2023 Category: Cancer & Oncology Authors: Makoto Ito, Yasuo Yoshioka, Yuuki Takase, Junji Suzuki, Hironori Takahashi, Yoshitaka Minami, Ami Sakuragi, Yukihiko Oshima, Takahito Okuda and Kojiro Suzuki Tags: Research Source Type: research
Dynamics in the expression of programmed death ligand 1 and cluster of differentiation 163 in the tumor microenvironment of uterine cervical cancer: a single-center retrospective study
Radiotherapy (RT) destroys cancer cells and activates the immune system while suppressing the immunity of tumor-associated tissues, including the tumor microenvironment (TME). However, to date, no anti-tumor t... (Source: Radiation Oncology)
Source: Radiation Oncology - February 23, 2023 Category: Cancer & Oncology Authors: Yusaku Miyata, Etsuyo Ogo, Toshi Abe, Hideki Hirata, Naotake Tsuda, Kimio Ushijima, Akihiko Kawahara, Jun Akiba, Hitoshi Obara and Tatsuyuki Kakuma Tags: Research Source Type: research
Postoperative radiotherapy for supraglottic cancer on real-world data: can we reduce dose to lymph node levels?
To evaluate prognosis for reducing postoperative radiotherapy (PORT) dose to lymph node levels of supraglottic cancer (SC) on real-world data. (Source: Radiation Oncology)
Source: Radiation Oncology - February 22, 2023 Category: Cancer & Oncology Authors: Yi Xu, Yumei Wei, Jingbo Wang, Jianghu Zhang, Xuesong Chen, Runye Wu, Qingfeng Liu, Yuan Qu, Kai Wang, Xiaodong Huang, Jingwei Luo, Wei Xu, Ye Zhang and Junlin Yi Tags: Research Source Type: research
Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study
Stereotactic ablative radiotherapy (SABR) is a validated treatment for early stage lung cancer and pulmonary metastases. It provides a high local control rate with low symptomatic toxicities. Recently, Dynamic... (Source: Radiation Oncology)
Source: Radiation Oncology - February 22, 2023 Category: Cancer & Oncology Authors: Emmanuel Mesny, Myriam Ayadi, Pauline Dupuis, Guillaume Beldjoudi, Ronan Tanguy and Isabelle Martel-Lafay Tags: Research Source Type: research
Biological target volume based on fluorine-18-fluorode-oxyglucose positron emission tomography/computed tomography imaging: a spurious proposition?
To assess whether the high metabolic region of fluorine-18-fluorode-oxyglucose (18F-FDG) in the primary lesion is the crux for recurrence in patients with nasopharyngeal carcinoma (NPC), to assess the feasibility... (Source: Radiation Oncology)
Source: Radiation Oncology - February 21, 2023 Category: Cancer & Oncology Authors: Ting Xu, Ye Feng, Huiling Hong, Yiying Xu, Jiawei Chen, Xiufang Qiu, Jianming Ding, Chaoxiong Huang, Li Li, Chuanben Chen and Zhaodong Fei Tags: Research Source Type: research
Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis
This study aimed to evaluate and conduct a meta-analysis on the efficacy and safety of proton beam therapy (PBT) for rhabdomyosarcoma (RMS). (Source: Radiation Oncology)
Source: Radiation Oncology - February 20, 2023 Category: Cancer & Oncology Authors: Meng Dong, Jianrong Wu, Renhua Wu, Dandan Wang, Ruifeng Liu, Hongtao Luo, Yuhang Wang, Junru Chen, Yuhong Ou, Qiuning Zhang and Xiaohu Wang Tags: Review Source Type: research
Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases
The objective of this study is to r... (Source: Radiation Oncology)
Source: Radiation Oncology - February 14, 2023 Category: Cancer & Oncology Authors: Siran Yang, Yuchao Ma, Yingjie Xu, Qingfeng Liu, Ye Zhang, Xiaodong Huang, Xuesong Chen, Kai Wang, Ruizhi Zhao, Jianping Xiao and Hongmei Zhang Tags: Research Source Type: research
Charged particle therapy for high-grade gliomas in adults: a systematic review
High-grade gliomas are the most common intracranial malignancies, and their current prognosis remains poor despite standard aggressive therapy. Charged particle beams have unique physical and biological proper... (Source: Radiation Oncology)
Source: Radiation Oncology - February 8, 2023 Category: Cancer & Oncology Authors: Yuhang Wang, Ruifeng Liu, Qiuning Zhang, Meng Dong, Dandan Wang, Junru Chen, Yuhong Ou, Hongtao Luo, Kehu Yang and Xiaohu Wang Tags: Review Source Type: research
Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors —retrospective study
The Graded Prognostic Assessment for lung cancer using molecular markers (Lung-molGPA) has not been validated for use with Japanese non-small cell lung cancer (NSCLC) patients with brain metastasis (BM) and th... (Source: Radiation Oncology)
Source: Radiation Oncology - February 7, 2023 Category: Cancer & Oncology Authors: Hajime Higaki, Kentaro Nishioka, Manami Otsuka, Noboru Nishikawa, Motoyasu Shido, Hideki Minatogawa, Yukiko Nishikawa, Rikiya Takashina, Takayuki Hashimoto, Norio Katoh, Hiroshi Taguchi, Rumiko Kinoshita, Koichi Yasuda, Takashi Mori, Yusuke Uchinami, Fuki Tags: Research Source Type: research
Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
To compare the efficacy and safety of postoperative extensive target volume irradiation with elevated radiation dose and concurrent chemotherapy with radiotherapy only for the postoperative treatment of esopha... (Source: Radiation Oncology)
Source: Radiation Oncology - February 7, 2023 Category: Cancer & Oncology Authors: Dashan Ai, Yun Chen, Qi Liu, Jiaying Deng, Xiaofei Zhang, Junhua Zhang, Li Chu, Jingyi Shen, Longfei Ma, Yawei Zhang, Haiquan Chen, Longsheng Miao, Kuaile Zhao and Jiaqing Xiang Tags: Research Source Type: research
